BackBoston Scientific Overview
Boston Scientific Corp.

Boston Scientific Target Price

See Boston Scientific's analyst price targets ($67) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$48.3

Average Target Price

$66.9738.6% upside

29 analysts in the last 4 months

High: $89 | Low: $50

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-30UBS$6738.7% upsideOpen
2026-07-30Leerink Partners$6024.2% upsideOpen
2026-07-30Canaccord Genuity$6636.6% upsideOpen
2026-07-30RBC CapitalShagun Singh$7044.9% upsideOpen
2026-07-30Wells Fargo$503.5% upsideOpen
2026-07-30Deutsche BankPito Chickering$6024.2% upsideOpen
2026-07-30Raymond JamesJayson Bedford$5718% upsideOpen
2026-07-30Robert W. Baird$5615.9% upsideOpen
2026-07-29Stifel NicolausRick Wise$6024.2% upsideOpen
2026-07-29BTIGMarie Thibault$6024.2% upsideOpen
2026-07-28UBS$7453.2% upsideOpen
2026-07-27Oppenheimer$8576% upsideOpen
2026-07-16Truist Financial$6228.4% upsideOpen
2026-07-15Mizuho SecuritiesAnthony Petrone$7044.9% upsideOpen
2026-07-13RBC CapitalShagun Singh$8576% upsideOpen
2026-07-08NeedhamMike Matson$5718% upsideOpen
2026-07-06Evercore ISI$6534.6% upsideOpen
2026-06-25Stifel Nicolaus$6534.6% upsideOpen
2026-06-12Piper Sandler$6534.6% upsideOpen
2026-06-04Truist Financial$6432.5% upsideOpen
2026-06-02BTIGMarie Thibault$6534.6% upsideOpen
2026-06-01Canaccord Genuity$7044.9% upsideOpen
2026-05-28Goldman Sachs$7147% upsideOpen
2026-05-28Robert W. Baird$7044.9% upsideOpen
2026-05-28Wells FargoLarry Biegelsen$5513.9% upsideOpen
2026-05-28Barclays$8984.3% upsideOpen
2026-05-28Leerink PartnersMike Kratky$7453.2% upsideOpen
2026-05-27Stifel NicolausRick Wise$7555.3% upsideOpen
2026-05-19Robert W. Baird$7555.3% upsideOpen
2026-04-29Daiwa$6024.2% upsideOpen
2026-04-23RBC Capital$100107% upsideOpen
2026-04-23Robert W. Baird$7861.5% upsideOpen
2026-04-23Wells Fargo$7555.3% upsideOpen
2026-04-23Canaccord GenuityWilliam Plovanic$7147% upsideOpen
2026-04-23Truist Financial$8576% upsideOpen
2026-04-23NeedhamMike Matson$7759.4% upsideOpen
2026-04-23Oppenheimer$9086.3% upsideOpen
2026-04-23BarclaysMatt Miksic$9698.8% upsideOpen
2026-04-22JefferiesMatthew Taylor$100107% upsideOpen
2026-04-22Goldman SachsDavid Roman$8473.9% upsideOpen
2026-04-21Stifel NicolausRick Wise$8576% upsideOpen
2026-04-15Truist Financial$9086.3% upsideOpen
2026-04-13Mizuho Securities$9086.3% upsideOpen
2026-03-26Goldman Sachs$9392.5% upsideOpen
2026-02-17Canaccord GenuityWilliam Plovanic$109125.7% upsideOpen
2026-02-06BernsteinLee Hambright$112131.9% upsideOpen
2026-02-05Mizuho Securities$115138.1% upsideOpen
2026-02-05Needham$97100.8% upsideOpen
2026-02-05RBC Capital$115138.1% upsideOpen
2026-02-05Truist Financial$9596.7% upsideOpen

Boston Scientific (BSX) FAQ

As of the most recent data, BSX shows a target price of $67. Scroll down for historical charts and peer comparison views.

If Boston Scientific moved to the average analyst target of $67, shares would be roughly 38.6% higher than $48.3. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Boston Scientific's earnings trajectory.

Besides this target price page, Stockcircle has Boston Scientific's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $67) with ownership activity and broader fundamentals.

Boston Scientific's target price is $67; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.